Modulation of PAI-1 and proMMP-9 syntheses by soluble TNF? and its receptors during differentiation of the human monocytic HL-60 cell line

This publication has 28 references indexed in Scilit:

• Transgenic mouse models in angiogenesis and cardiovascular disease
  The Journal of Pathology, 2000
• Very Low Density Lipoprotein–Mediated Signal Transduction and Plasminogen Activator Inhibitor Type 1 in Cultured HepG2 Cells
  Circulation Research, 1999
• On the Role of c-Jun in the Induction of PAI-1 Gene Expression by Phorbol Ester, Serum, and IL-1α in HepG2 Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
  FEBS Letters, 1998
• Induction of Unresponsiveness to Tumor Necrosis Factor (TNF) after Autocrine TNF Expression Requires TNF Membrane Retention
  Journal of Biological Chemistry, 1998
• Production and Activation of Matrix Metalloprotease-9 (MMP-9) by HL-60 Promyelocytic Leukemia Cells
  Biochemical and Biophysical Research Communications, 1997
• A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
  Nature, 1997
• Phagocytic Activation Induces Formation of Platelet‐Activating Factor in Human Monocyte‐Derived Macrophages and in Macrophage‐Derived foam Cells
  European Journal of Biochemistry, 1996
• Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate.
  Endocrinology, 1992
• Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
  The Journal of Experimental Medicine, 1992